Table 2.
Basic characteristic of the leprosy patients and the controls.
| Classification | Number of cases | Age (years) | Gender (n, %) | Ethnicities (n, %) | |||||
|---|---|---|---|---|---|---|---|---|---|
| Male | Female | Li | Han | Miao | Hui | ||||
| Leprosy | 71 | 61.9 ± 14.5 | 48 (67.6) | 23 (32.4) | 52(73.2) | 16(22.5) | 2(2.8) | 1(1.4) | |
| Controls | 29 | 57.6 ± 17.9 | 17(58.6) | 12 (41.4) | No data | No data | No data | No data | |
| WHO* | MB | 34 | 63.2 ± 14.9 | 22(64.7) | 12(35.3) | 26(76.5) | 6(17.7) | 1(2.9) | 1(2.9) |
| PB | 37 | 62.6 ± 14.3 | 26(70.3) | 11(29.7) | 26(70.3) | 10(27.0) | 1(2.7) | 0(0.0) | |
| Ridley-Jopling** | TT | 26 | 66.2 ± 12.3 | 18(69.2) | 8(30.8) | 22(84.6) | 2(7.7) | 1(3.8) | 1(3.8) |
| BT | 8 | 49.3 ± 14.4 | 4(50.0) | 4(50.0) | 4(50.0) | 4(50.0) | 0(0.0) | 0(0.0) | |
| BB | 6 | 59 ± 21.5 | 5(83.3) | 1(16.7) | 3(50.0) | 3(50.0) | 0(0.0) | 0(0.0) | |
| BL | 8 | 57 ± 13.6 | 7(87.5) | 1(12.5) | 6(75.0) | 2(25.0) | 0(0.0) | 0(0.0) | |
| LL | 23 | 66.2 ± 11.9 | 14(60.9) | 9(39.1) | 17(73.9) | 5(21.7) | 1(4.3) | 0(0.0) | |
| Reaction | R | 8 | 41.6 ± 10.8 | 7(87.5) | 1(12.5) | 3(37.5) | 5(62.5) | 0(0.0) | 0(0.0) |
| NR | 63 | 65.6 ± 12.6 | 41(65.1) | 22(34.9) | 49(77.8) | 11(17.5) | 2(3.2) | 1(1.5) | |
| Disability | D | 51 | 65.5 ± 11.9 | 34(66.7) | 17(33.4) | 42(82.4) | 6(11.8) | 2(3.9) | 1(1.9) |
| ND | 20 | 56.1 ± 18.2 | 14(70.0) | 6(30.0) | 10(50.0) | 10(50.0) | 0(0.0) | 0(0.0) | |
| Longer | 53 | 68.3 ± 10.6 | 32(60.4) | 21(39.6) | 43(81.1) | 7(13.2) | 2(3.8) | 1(1.9) | |
| Shorter | 18 | 46.9 ± 12.5 | 16(88.9) | 2(11.1) | 9(50.0) | 9(50.0) | 0(0.0) | 0(0.0) | |
n: number of patients, with percentages in parentheses. *WHO: Operational classification proposed by the World Health Organization. **RJ: Ridley-Jopling classification. NR: no reaction; ND: no disability; D:disability; No data: no data collected.